Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Nivolumab market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Nivolumabmarket, defines the market attractiveness level of Nivolumab market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Nivolumab industry, describes the types of Nivolumab market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nivolumab market and the development prospects and opportunities of Nivolumab industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nivolumab market in Chapter 13.
By Player:
Ono Pharmaceutical
Bristol-Myers Squibb
By Type:
Injection 4mL
Injection 10mL
By End-User:
Unresectable Melanoma
Metastatic Melanoma
Metastatic Squamous NSCLC
Classical Hodgkin Lymphoma
Renal Cell Carcinoma
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Nivolumab Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Nivolumab Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Nivolumab Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Nivolumab Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Nivolumab Market Analysis and Outlook to 2022
-
7.1 Global Nivolumab Consumption (2017-2022)
-
7.2 United States Nivolumab Consumption (2017-2022)
-
7.3 Europe Nivolumab Consumption (2017-2022)
-
7.4 China Nivolumab Consumption (2017-2022)
-
7.5 Japan Nivolumab Consumption (2017-2022)
-
7.6 India Nivolumab Consumption (2017-2022)
-
7.7 South Korea Nivolumab Consumption (2017-2022)
8 Region and Country-wise Nivolumab Market Analysis and Outlook to 2028
-
8.1 Global Nivolumab Consumption Forecast (2022-2028)
-
8.2 United States Nivolumab Consumption Forecast (2022-2028)
-
8.3 Europe Nivolumab Consumption Forecast (2022-2028)
-
8.4 China Nivolumab Consumption Forecast (2022-2028)
-
8.5 Japan Nivolumab Consumption Forecast (2022-2028)
-
8.6 India Nivolumab Consumption Forecast (2022-2028)
-
8.7 South Korea Nivolumab Consumption Forecast (2022-2028)
9 Global Nivolumab Market Outlook by Types and Applications to 2022
-
9.1 Global Nivolumab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Injection 4mL Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Injection 10mL Consumption and Growth Rate (2017-2022)
-
9.2 Global Nivolumab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Unresectable Melanoma Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Metastatic Melanoma Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Metastatic Squamous NSCLC Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Classical Hodgkin Lymphoma Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Renal Cell Carcinoma Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Other Consumption and Growth Rate (2017-2022)
10 Global Nivolumab Market Outlook by Types and Applications to 2028
-
10.1 Global Nivolumab Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Injection 4mL Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Injection 10mL Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Nivolumab Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Unresectable Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Metastatic Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Metastatic Squamous NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Classical Hodgkin Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Renal Cell Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Nivolumab Import and Export Analysis (Top 5 Countries)
-
11.1 Global Nivolumab Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Nivolumab Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Nivolumab Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Nivolumab Market Competitive Analysis
-
14.1 Ono Pharmaceutical
-
14.1.1 Ono Pharmaceutical Company Details
-
14.1.2 Ono Pharmaceutical Nivolumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Ono Pharmaceutical Nivolumab Product and Service
-
14.2 Bristol-Myers Squibb
-
14.2.1 Bristol-Myers Squibb Company Details
-
14.2.2 Bristol-Myers Squibb Nivolumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Nivolumab Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Nivolumab
-
Figure Nivolumab Picture
-
Table Global Nivolumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Nivolumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Nivolumab Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Nivolumab Consumption by Country (2017-2022)
-
Figure United States Nivolumab Consumption and Growth Rate (2017-2022)
-
Table Europe Nivolumab Consumption and Growth Rate (2017-2022)
-
Figure China Nivolumab Consumption and Growth Rate (2017-2022)
-
Figure Japan Nivolumab Consumption and Growth Rate (2017-2022)
-
Figure India Nivolumab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Nivolumab Consumption and Growth Rate (2017-2022)
-
Figure Global Nivolumab Consumption Forecast by Country (2022-2028)
-
Figure United States Nivolumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Nivolumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Nivolumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Nivolumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Nivolumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Nivolumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection 4mL Consumption and Growth Rate (2017-2022)
-
Figure Global Injection 10mL Consumption and Growth Rate (2017-2022)
-
Figure Global Unresectable Melanoma Consumption and Growth Rate (2017-2022)
-
Figure Global Metastatic Melanoma Consumption and Growth Rate (2017-2022)
-
Figure Global Metastatic Squamous NSCLC Consumption and Growth Rate (2017-2022)
-
Figure Global Classical Hodgkin Lymphoma Consumption and Growth Rate (2017-2022)
-
Figure Global Renal Cell Carcinoma Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Injection 4mL Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection 10mL Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Unresectable Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metastatic Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metastatic Squamous NSCLC Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Classical Hodgkin Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Renal Cell Carcinoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Nivolumab Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Nivolumab Export by Region (Top 5 Countries) (2017-2028)
-
Table Ono Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Ono Pharmaceutical Nivolumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ono Pharmaceutical Nivolumab Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Nivolumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Nivolumab Product and Service
-
